PTCB Guide to Bisphosphonates

Also called the -dronate bone drugs · suffix -dronate · updated August 7, 2026

What gets tested

• Recognizing the -dronate suffix and matching brand to generic (Fosamax is alendronate, Actonel is risedronate, Boniva is ibandronate, Reclast is zoledronic acid)
• The full administration and counseling protocol, which is the single highest-yield element of this class
• Why the drug must be taken with plain water and not coffee, juice, or mineral water
• The chelation problem with calcium, antacids, and iron, and the timing that follows
• Osteonecrosis of the jaw and the dental care advice that goes with it
• The weekly, monthly, and yearly dosing options and what each product is

What is not tested

You are not expected to interpret a bone density scan, decide treatment duration, or manage a drug holiday. What matters is the suffix, the brand and generic pairs, the administration protocol in full, and the warning signs patients are told to report. Strengths, dosage forms, routes, special handling, and administration instructions are explicitly inside PTCE knowledge area 1.4, and this class is close to a model question for that objective.

Why bisphosphonates matter

Alendronate is widely dispensed for osteoporosis, and no other common oral medicine carries such a specific and consequential set of administration instructions. Getting them wrong causes real harm, from esophageal ulceration to a drug that simply does not absorb. That combination makes bisphosphonates one of the most reliably tested counseling scenarios on the exam.

Bisphosphonates at a glance

Mechanism of action

Bone is not static. Osteoclasts constantly dissolve small patches of it and osteoblasts rebuild them, and osteoporosis develops when the dissolving outpaces the rebuilding. Bisphosphonates are chemical analogues of pyrophosphate, a natural component of bone mineral, and they have an extremely high affinity for hydroxyapatite, the calcium crystal that makes bone hard. Given by mouth or by infusion, they travel to the skeleton and bind tightly to exposed mineral surfaces, concentrating exactly where resorption is most active. When an osteoclast then attaches to that surface and begins dissolving it, the drug is released into the acidic pocket beneath the cell and taken up. Inside the osteoclast, the nitrogen-containing bisphosphonates such as alendronate and zoledronic acid inhibit farnesyl pyrophosphate synthase, an enzyme in the pathway that produces the lipid anchors the cell needs to maintain its ruffled border and stay attached to bone. The osteoclast loses its ability to resorb and undergoes programmed cell death. Resorption slows, the rebuilding side catches up, and bone density rises modestly while fracture risk falls. Two practical consequences follow from the chemistry. First, that same affinity for calcium means any calcium in the gut, from food, dairy, supplements, antacids, or even mineral-rich water, will bind the drug before it can be absorbed. Oral absorption is already extremely poor, well under one percent, so anything in the stomach effectively wipes it out. Second, the drug binds to bone for years, which is why effects persist long after the last dose and why long-term use is linked to the rare complications of jaw osteonecrosis and atypical femoral fracture.

Common and important side effects

• Esophageal irritation, inflammation, and ulceration, especially if the patient lies down or takes too little water
• Heartburn, abdominal pain, nausea, and difficulty swallowing
• Musculoskeletal pain in bones, joints, or muscles, occasionally severe
• Osteonecrosis of the jaw, a rare failure of jaw bone to heal, most often following dental extraction or in cancer patients on high-dose intravenous therapy
• Atypical femur fracture, a rare fracture of the thigh bone often preceded by weeks of dull thigh or groin pain
• An acute phase reaction after intravenous dosing: fever, muscle aches, and flu-like symptoms for a day or two
• Low blood calcium, particularly if vitamin D is deficient
• Eye inflammation, which is uncommon

Key interactions

• Calcium supplements, antacids, iron, and magnesium bind the drug and block the little absorption there is, so they are separated by at least 30 minutes and usually longer
• Any food or beverage other than plain water reduces absorption dramatically
• NSAIDs add to the risk of gastrointestinal irritation
• Proton pump inhibitors may reduce the effectiveness of some oral bisphosphonates
• Loop diuretics and other drugs that lower calcium can deepen hypocalcemia

Patient counseling notes

• Take the tablet first thing in the morning after getting up, before any food, drink, or other medicine
• Swallow it whole with a full glass, roughly 6 to 8 ounces, of plain water. Not coffee, tea, juice, milk, or mineral water, because minerals bind the drug
• Stay fully upright, sitting or standing, for at least 30 minutes afterwards. Ibandronate requires 60 minutes. Do not lie down
• Wait at least 30 minutes, and ideally until after the first food of the day, before taking anything else, including calcium and vitamin D
• Do not chew or suck the tablet, because it can ulcerate the mouth and throat
• Tell your dentist you take this medicine, and try to complete major dental work before starting long-term therapy
• Report new or worsening heartburn, painful or difficult swallowing, or chest pain under the breastbone
• Report persistent thigh or groin pain, which can precede an unusual fracture, and any jaw pain or non-healing dental socket

Practice questions

Work the Bisphosphonates questions below first, then widen out. Two skills carry most of the Medications domain, and each has its own quiz. The first is drug class identification: recognising which class a drug belongs to from its name or its stem, which is what the drug class identification quiz drills across every class. The second is brand and generic recall, because the exam switches between the two names freely and expects you to follow. Pair this guide with the brand and generic quiz until the brand and generic pairs in the table above come back without effort.

Related drug-class guides

Official sources

• MedlinePlus: Alendronate
• MedlinePlus: Risedronate
• MedlinePlus: Ibandronate
• MedlinePlus: Zoledronic Acid Injection
• MedlinePlus: Osteoporosis (topic overview)
• ClinCalc DrugStats: Alendronate (dispensing data)

PTCB Quiz Prep is an independent study resource, not affiliated with the Pharmacy Technician Certification Board. This guide is for exam preparation, not medical advice. Part of the PTCB Medications domain.